Medical News

RSS

Low-income groups slow to seek treatment for stroke

People with lower incomes are less likely to present at a hospital within 3 hours of stroke symptoms and thus have lower rates of thrombolysis therapy or post-stroke care than their more affluent counterparts, according to a retrospective analysis.

22 Jan 2013

Neural clues found for impaired emotional response in bipolar disorder

Researchers have identified distinct trait- and state-related neural abnormalities during emotional response inhibition in patients with bipolar disorder.

22 Jan 2013

Tell tale neurologic soft signs for schizophrenia and bipolar disorder

Neurologic soft signs can differentiate schizophrenia from major depression but not bipolar disorder, study findings indicate.

22 Jan 2013

Simulation ticks box for checklists in surgical care

The management of operating-room crises could be significantly improved by using checklists, say researchers in the New England Journal of Medicine.

22 Jan 2013

Routine gastric volume monitoring thrown out

Monitoring gastric residual volumes in critically ill patients receiving enteral nutrition does not prevent them from developing ventilator-associated pneumonia, shows a randomized trial.

22 Jan 2013

Eardrum crust aids perforation healing if timing is right

How and when “crust” forms at the margin of a tympanic membrane perforation may serve as a predictor for healing outcome, research suggests.

22 Jan 2013

Ultrasound strategy excludes DVT in pregnant women

Serial compression ultrasonography with iliac vein visualization can reliably exclude deep vein thrombosis in symptomatic pregnant women, according to results from an 8-year prospective cohort study published in the Canadian Medical Association Journal.

22 Jan 2013

Amyloid clue to Parkinson’s dementia

Study findings link amyloid β burden to future cognitive decline in patients with Parkinson’s disease.

22 Jan 2013

Team support aids Parkinson’s patients

A randomized controlled trial demonstrates improved outcomes if patients with Parkinson’s disease are cared for by a multidisciplinary team.

22 Jan 2013

Imaging supports Braak Parkinson’s staging

A magnetic resonance imaging study supports the hypothesis that degeneration occurs in the substantia nigra pars compacta before the basal forebrain in patients with Parkinson’s disease.

22 Jan 2013

STN confirmed as preferred stimulation target in Parkinson’s

Subthalamic nucleus stimulation is at worst equivalent and at best superior to globus pallidus pars interna stimulation in patients with Parkinson’s disease, shows a randomized trial.

22 Jan 2013

Intelligent algorithms for programming deep brain stimulation in Parkinson’s to be developed by Great Lakes NeuroTechnologies

Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson’s disease.

22 Jan 2013

Chronic heart failure treatment, Inspra (eplerenone), accepted for use within NHS Wales

Inspra (eplerenone) has now been accepted by the All Wales Medicines Strategy Group (AWMSG) for use in adult patients with chronic heart failure (CHF) NYHA class II, in combination with standard optimal therapy...

22 Jan 2013

PathCentral announces roll-out of new pathology network

PathCentral, a technology-enabled company dedicated to the success of the international pathology community, and China-based Kindstar Globalgene Technology, Inc., today announced the roll-out of the PathCentral Pathology Network, an online professional pathology network that will enable Kindstar to access US pathologists and facilitate pathology consultations for more than 3,300 hospitals throughout China.

22 Jan 2013

Psychiatrist claims medical marijuana dangerous for treatment of psychiatric problems

Using medical marijuana to treat conditions such as anxiety and depression is dangerous and has no basis in medical science, says Dr. Timothy R. Jennings, a prominent Tennessee psychiatrist and consultant to The Center for Counseling and Health Resources in Edmonds, WA.

22 Jan 2013

Calmangafodipir protects against side effects of cancer treatments

A drug developed at Linköping University in Sweden protects against the side effects of cancer treatments while strengthening the effects on the tumour.

22 Jan 2013

New special issue explores link between evolution and the body's fight against cancer

Over 500 billion cells in our bodies will be replaced daily, yet natural selection has enabled us to develop defenses against the cellular mutations which could cause cancer. It is this relationship between evolution and the body's fight against cancer which is explored in a new special issue of the Open Access journal Evolutionary Applications.

22 Jan 2013

Dutasteride decreases risk of biopsy detectable prostate cancer by 22.8%

The four-year REDUCE (REduction by DUtasteride of prostate Cancer Events) clinical study evaluated prostate cancer risk reduction in men taking dutasteride, a 5-alpha-reductase inhibitor (5ARI) typically used to treat enlarged prostate.

22 Jan 2013

Simcere enters share transfer agreement with Devont Asset Management

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.

22 Jan 2013

Russia approves FzioMed’s Oxiplex gel for lumbar spine surgery

FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the approval of Oxiplex in Russia. Oxiplex is an absorbable, clear, viscoelastic gel that is applied during lumbar spine surgery immediately prior to wound closure.

22 Jan 2013